It could be “truly catastrophic” if two federal appeals courts rule as a third already has that drug makers do not have to deliver 340B drugs to multiple contract pharmacies, 340B Health President and CEO Maureen Testoni said at the 340B Coalition summer conference.
Adverse Appellate Rulings in Contract Pharmacy Cases Could Be “Truly Catastrophic,” 340B Health’s Testoni Says
It could be “truly catastrophic” if two federal appeals courts rule as a third did in January that drug manufacturers [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
